3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
30
Burkitt Lymphoma
12
Lung Neoplasms
11
Leukemia, Myeloid, Acute
11
Recurrence
10
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Lymphoma
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma, Large B-Cell, Diffuse
8
Lymphoma, Non-Hodgkin
7
Hodgkin Disease
7
Carcinoma, Non-Small-Cell Lung
7
Neuroblastoma
4
Lymphoma, B-Cell
4
Leukemia
4
Wilms Tumor
3
Sarcoma, Ewing
3
Plasmablastic Lymphoma
3
Neoplasms, Germ Cell and Embryonal
3
Neoplasms
3
Myelodysplastic Syndromes
3
Multiple Myeloma
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, T-Cell
3
Lymphoma, Mantle-Cell
3
Lymphoma, Follicular
3
Immunoblastic Lymphadenopathy
3
Ganglioneuroblastoma
3
Teratoma
2
Sarcoma
2
Interventions
Nivolumab
2
Ipilimumab
2
spartalizumab
1
poly ICLC
1
balstilimab
1
atezolizumab
1
Specimen Handling
1
Sorafenib
1
Irinotecan
1
DT2216
1
Cyclophosphamide
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Fibrolamellar hepatocellular carcinoma
×
Etoposide
×
90 days
×
Clear all
No trials found.